FDA wants guidance on guidances

FDA wants guidance on guidances

CBER guidance documents in the works cover chemistry, manufacturing and control of products based on naturally derived proteins and on gene therapy products, as well as a guidance on monoclonal antibodies and orphan drug designation.

Xenotransplantation would be covered in another planned

Read the full 465 word article

How to gain access

Continue reading with a
two-week free trial.